ClinicalTrials.Veeva

Menu

Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion

U

Université de Sherbrooke

Status and phase

Enrolling
Phase 1

Conditions

Trigeminal Neuralgia

Treatments

Device: Deep brain stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT05451251
2025-4672

Details and patient eligibility

About

The aim of this study is to assess the feasibility of deep brain stimulation for refractory trigeminal neuralgia due to a pontine lesion, as is usually seen in the context of multiple sclerosis.

These patients usually have severe intractable facial pain and current medical and surgical options generally fail to achieve long lasting pain relief.

Hoping to improve pain control in this population, the investigators of this trial propose a novel technique consisting of implanting a deep brain stimulation lead within the pontine lesion to modulate the generation of pain signals.

Enrollment

6 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults of at least 18 years old
  • Refractory trigeminal neuralgia : failure of at least 3 drugs and at least two lesioning surgical interventions (radiosurgery, percutaneous rhizotomy, or open rhizotomy).
  • Pontine lesion proved by MRI in contact with trigeminal nerve tract

Exclusion criteria

  • Absolute contraindication to MRI
  • Medical contraindication to the procedure

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

6 participants in 1 patient group

Deep brain stimulation
Experimental group
Description:
Implantation of deep brain stimulation lead within the pontine lesion
Treatment:
Device: Deep brain stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Christian Iorio-Morin, MD, PhD, FRCS(C)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems